No profile data available.
Medicus Pharma Ltd. (MDCX) is a healthcare company in the additional cancer treatment drugs industry, based in West Conshohocken, United States, with about 16 full-time employees.
It reported revenue of $0 for fiscal year 2025, and net income of -$47.28 million. Its market capitalization was $138,068 as of October 9, 2026.
Figures from company filings and market data; latest fiscal year ended December 31, 2025; market data as of October 9, 2026.
, a biotech/life sciences company, focuses on developing clinical development programs of therapeutic assets in the United States. It is developing SKNJCT-003, which is in Phase 2 study for the treatment of basal cell carcinoma of the skin.
Medicus Pharma reported $0 in revenue for fiscal year 2025.
$138,068 as of October 9, 2026.
Listed companies of a similar size in the same industry (additional cancer treatment drugs) include Ocean Biomedical, Inc. (OCEA), Regen BioPharma, Inc. (RGBP), Cnbx Pharmaceuticals Inc. (CNBX), Nascent Biotech, Inc. (NBIO).